The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation

PURPOSE: Recently, bortezomib has been used to treat antibody-mediated rejection (AMR) refractory to conventional treatment such as plasmapheresis, intravenous immunoglobulin, and rituximab. The authors aimed to describe their experiences when bortezomib was used to treat refractory AMR. MATERIALS A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Yonsei Med J
Hlavní autoři: Lee, Juhan, Kim, Beom Seok, Park, Yongjung, Lee, Jae Geun, Lim, Beom Jin, Jeong, Hyeon Joo, Kim, Yu Seun, Huh, Kyu Ha
Médium: Artigo
Jazyk:Inglês
Vydáno: Yonsei University College of Medicine 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4630054/
https://ncbi.nlm.nih.gov/pubmed/26446648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2015.56.6.1638
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky